Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

References

• EL Andaloussi S, Mager I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12: 347–57. [PubMed Abstract].
   Google Scholar
• Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20: 847–56.
   Google Scholar
• Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91.
   Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008; 10: 619–24.
   Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9.
   Google Scholar
• Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med. 2011; 9: 86.
   Google Scholar
• Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012; 10: 5.
   Google Scholar
• Lasser C, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011; 9: 9.
   Google Scholar
• Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004; 101: 13368–73.
   Google Scholar
• Yamada T, Inoshima Y, Matsuda T, Ishiguro N. Comparison of methods for isolating exosomes from bovine milk. J Vet Med Sci. 2012; 74: 1523–5.
   Google Scholar
• Bellingham SA, Guo BB, Coleman BM, Hill AF. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?. Front Physiol. 2012; 3: 124.
   Google Scholar
• Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010; 30: 6838–51.
   Google Scholar
• Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011; 6: 481–92.
   Google Scholar
• Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, Van Oorschot AA et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 2011; 6: 206–14.
   Google Scholar
• Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011; 26: 1474–83.
   Google Scholar
• Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998; 4: 594–600.
   Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29: 341–5.
   Google Scholar
• Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014; 28: 970–3. [PubMed Abstract].
   Google Scholar
• Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med. 2014; 33: 1055–63. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Jang SC, Kim SR, Yoon YJ, Park KS, Kim JH, Lee J et al. In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria. Small. 2014; 11: 456–61.
   Google Scholar
• Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire CA, Chen JW et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014; 8: 483–94.
   Google Scholar
• Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165: 77–84.
   Google Scholar
• Ignowski JM, Schaffer DV. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng. 2004; 86: 827–34.
   Google Scholar
• Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2014; 199C: 145–55.
   Google Scholar
• Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013; 21: 185–91.
   Google Scholar
• Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014; 35: 2383–90.
   Google Scholar
• Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371: 1579–86.
   Google Scholar
• Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007; 21: 1733–8.
   Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P et al. Sizing and phenotyping of cellular vesicles using Nanoparticle tracking analysis. Nanomedicine. 2011; 7: 780–8.
   Google Scholar
• Niska JA, Meganck JA, Pribaz JR, Shahbazian JH, Lim E, Zhang N et al. Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and muCT imaging in an orthopaedic implant infection in mice. PLoS One. 2012; 7: e47397.
   Google Scholar
• Patel AR, Lim E, Francis KP, Singh M. Opening up the optical imaging window using nano-luciferin. Pharm Res. 2014; 31: 3073–84.
   Google Scholar
• Herschman HR. Molecular imaging: looking at problems, seeing solutions. Science. 2003; 302: 605–8.
   Google Scholar
• Hilderbrand SA, Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol. 2010; 14: 71–9.
   Google Scholar
• Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011; 32: 7127–38.
   Google Scholar
• Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol. 2003; 13: 195–208. [PubMed Abstract].
   Google Scholar
• Kalchenko V, Shivtiel S, Malina V, Lapid K, Haramati S, Lapidot T et al. Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Optics. 2006; 11: 050507.
   Web of Science ®Google Scholar
• Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics. 2009; 9: 4997–5000.
   Google Scholar
• Lopez-Berestein G, Kasi L, Rosenblum MG, Haynie T, Jahns M, Glenn H et al. Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res. 1984; 44: 375–8. [PubMed Abstract].
   Google Scholar
• Rank A, Nieuwland R, Crispin A, Grutzner S, Iberer M, Toth B et al. Clearance of platelet microparticles in vivo. Platelets. 2011; 22: 111–16.
   Google Scholar
• Ostro MJ, Cullis PR. Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm. 1989; 46: 1576–87. [PubMed Abstract].
   Google Scholar
• Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta. 1992; 1104: 95–101.
   Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001; 53: 283–318. [PubMed Abstract].
   Google Scholar
• Sarin H. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenesis Res. 2010; 2: 14.
   PubMedGoogle Scholar
• Garnett MC, Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup Med. 2006; 56: 307–11.
   Google Scholar
• Kupiec-Weglinski JW, Austyn JM, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med. 1988; 167: 632–45.
   Google Scholar
• Rana S, Yue S, Stadel D, Zoller M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol. 2012; 44: 1574–84.
   Google Scholar
• Rana S, Zoller M. Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem Soc Trans. 2011; 39: 559–62.
   Google Scholar
• Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011; 153: 198–205.
   Google Scholar
• Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007; 448: 39–43.
   Google Scholar
• Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet. 2001; 10: 2109–21.
   Google Scholar
• Pulford B, Reim N, Bell A, Veatch J, Forster G, Bender H et al. Liposome-siRNA-peptide complexes cross the blood–brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures. PLoS One. 2010; 5: e11085.
   Google Scholar
• Boksa P, Quirion R. [3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain. Eur J Pharmacol. 1987; 139: 323–33.
   Google Scholar
• Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. Is the acetylcholine receptor a rabies virus receptor?. Science. 1982; 215: 182–4.
   Google Scholar
• Lentz TL, Burrage TG, Smith AL, Tignor GH. The acetylcholine receptor as a cellular receptor for rabies virus. Yale J Biol Med. 1983; 56: 315–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 1987; 6: 3923–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar